09.09.15
Biotronik SE & Co. Kg has launched the CardioMessenger Smart 3G device in Japan.
The portable data-transmitter product, about the size of a smartphone, keeps pacemaker and implantable cardioverter defibrillator (ICD) wearers connected to their physicians, enabling safer, more efficient treatment at any time, nearly anywhere in the world, company executives claim. Japan is the first country to introduce the new transmitter and it will be rolled out in European countries throughout the rest of 2015.
Conventional remote monitoring systems in Japan require an AC adapter, so taking the transmitter outside is not possible. Because of this, data is usually only transmitted when the patient is at home. The CardioMessenger Smart 3G is equipped with a rechargeable internal battery, allowing patients to carry the transmitter like a mobile phone. The device enables continuous daily monitoring, regardless of the patient's lifestyle. Data can be transmitted to the physician through Biotronik's Home Monitoring, even if the patient is in a place without an AC adaptor when they develop arrhythmic events. Studies have shown home monitoring can reduce mortality rates.
"I believe that CardioMessenger Smart 3G will improve the therapeutic quality as it increases prompt reactions by physicians," said Eiichi Watanabe, M.D., Ph.D., a professor in the Department of Cardiology at Fujita Health University School of Medicine, in Aichi Prefecture, Toyoake, Japan. "In addition, it's very comforting to patients who feel that they are always taken care of when they carry their CardioMessenger Smart 3G."
Watanabe was the principal investigator for the Japanese Home ICD study that evaluated the reliability of ICD Home Monitoring in forecasting the need for regular office visits and patient perspective. Judged by an independent committee, the study found that remote monitoring correctly forecasted 75.1 percent of non-necessity remote follow-ups and 94.5 percent of the patient population were comfortable with the technology.
CardioMessenger Smart 3G sends information from the device to the Biotronik Home Monitoring Service Center using wireless radio frequency telemetry and coded data transmission for maximum safety and security, the company noted in a brief news release. Consistent and reliable data transmission occurs both daily and when triggered by an event. A call back message for patients enables physicians to get in contact with their patients whenever necessary.
"More than 10,000 Japanese hearts are already safely taken care of with Biotronik Home Monitoring," said Jeffrey Annis, managing director Biotronik Japan. "With the launch of the CardioMessenger Smart in Japan, more patients will have the peace of mind knowing that they can take this technology with them at anytime and anywhere."
Biotronik is based in Berlin, Germany, and has a global workforce of more than 5,600 employees. Its U.S. headquarters is located in Lake Oswego, Ore.
The portable data-transmitter product, about the size of a smartphone, keeps pacemaker and implantable cardioverter defibrillator (ICD) wearers connected to their physicians, enabling safer, more efficient treatment at any time, nearly anywhere in the world, company executives claim. Japan is the first country to introduce the new transmitter and it will be rolled out in European countries throughout the rest of 2015.
Conventional remote monitoring systems in Japan require an AC adapter, so taking the transmitter outside is not possible. Because of this, data is usually only transmitted when the patient is at home. The CardioMessenger Smart 3G is equipped with a rechargeable internal battery, allowing patients to carry the transmitter like a mobile phone. The device enables continuous daily monitoring, regardless of the patient's lifestyle. Data can be transmitted to the physician through Biotronik's Home Monitoring, even if the patient is in a place without an AC adaptor when they develop arrhythmic events. Studies have shown home monitoring can reduce mortality rates.
"I believe that CardioMessenger Smart 3G will improve the therapeutic quality as it increases prompt reactions by physicians," said Eiichi Watanabe, M.D., Ph.D., a professor in the Department of Cardiology at Fujita Health University School of Medicine, in Aichi Prefecture, Toyoake, Japan. "In addition, it's very comforting to patients who feel that they are always taken care of when they carry their CardioMessenger Smart 3G."
Watanabe was the principal investigator for the Japanese Home ICD study that evaluated the reliability of ICD Home Monitoring in forecasting the need for regular office visits and patient perspective. Judged by an independent committee, the study found that remote monitoring correctly forecasted 75.1 percent of non-necessity remote follow-ups and 94.5 percent of the patient population were comfortable with the technology.
CardioMessenger Smart 3G sends information from the device to the Biotronik Home Monitoring Service Center using wireless radio frequency telemetry and coded data transmission for maximum safety and security, the company noted in a brief news release. Consistent and reliable data transmission occurs both daily and when triggered by an event. A call back message for patients enables physicians to get in contact with their patients whenever necessary.
"More than 10,000 Japanese hearts are already safely taken care of with Biotronik Home Monitoring," said Jeffrey Annis, managing director Biotronik Japan. "With the launch of the CardioMessenger Smart in Japan, more patients will have the peace of mind knowing that they can take this technology with them at anytime and anywhere."
Biotronik is based in Berlin, Germany, and has a global workforce of more than 5,600 employees. Its U.S. headquarters is located in Lake Oswego, Ore.